Literature DB >> 29967347

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.

Carsten Krieg1,2, Malgorzata Nowicka3,4, Silvia Guglietta5, Sabrina Schindler6, Felix J Hartmann7, Lukas M Weber3,4, Reinhard Dummer6, Mark D Robinson3,4, Mitchell P Levesque8, Burkhard Becher9.   

Abstract

In the version of this article initially published, Figs. 5a,c and 6a were incorrect because of an error in a metadata spreadsheet that led to the healthy donor patient 2 (HD2) samples being used twice in the analysis of baseline samples and in the analysis at 12 weeks of anti-PD-1 therapy, while HD3 samples had not been used.

Entities:  

Year:  2018        PMID： 29967347     DOI： 10.1038/s41591-018-0094-7

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  9 in total

1.  Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade.

Authors:  Michal Harel; Coren Lahav; Eyal Jacob; Nili Dahan; Itamar Sela; Yehonatan Elon; Shani Raveh Shoval; Galit Yahalom; Iris Kamer; Alona Zer; Ofer Sharon; David P Carbone; Adam P Dicker; Jair Bar; Yuval Shaked
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

2.  Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival.

Authors:  Annette M Molinaro; John K Wiencke; Gayathri Warrier; Devin C Koestler; Pranathi Chunduru; Ji Yoon Lee; Helen M Hansen; Sean Lee; Joaquin Anguiano; Terri Rice; Paige M Bracci; Lucie McCoy; Lucas A Salas; Brock C Christensen; Margaret Wrensch; Karl T Kelsey; Jennie W Taylor; Jennifer L Clarke
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 11.816

Review 3.  Integrating the Tumor Microenvironment into Cancer Therapy.

Authors:  Sabina Sanegre; Federico Lucantoni; Rebeca Burgos-Panadero; Luis de La Cruz-Merino; Rosa Noguera; Tomás Álvaro Naranjo
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

Review 4.  Monocyte heterogeneity and functions in cancer.

Authors:  Claire E Olingy; Huy Q Dinh; Catherine C Hedrick
Journal:  J Leukoc Biol       Date:  2019-02-18       Impact factor: 4.962

5.  Biomimetic Anti-PD-1 Peptide-Loaded 2D FePSe3 Nanosheets for Efficient Photothermal and Enhanced Immune Therapy with Multimodal MR/PA/Thermal Imaging.

Authors:  Xueyang Fang; Xianlin Wu; Zhendong Li; Lijun Jiang; Wai-Sum Lo; Guanmao Chen; Yanjuan Gu; Wing-Tak Wong
Journal:  Adv Sci (Weinh)       Date:  2020-11-25       Impact factor: 16.806

6.  Host response to immune checkpoint inhibitors contributes to tumor aggressiveness.

Authors:  Irina Khononov; Eyal Jacob; Ella Fremder; Nili Dahan; Michal Harel; Ziv Raviv; Boris Krastev; Yuval Shaked
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

7.  muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data.

Authors:  Helena L Crowell; Charlotte Soneson; Pierre-Luc Germain; Daniela Calini; Ludovic Collin; Catarina Raposo; Dheeraj Malhotra; Mark D Robinson
Journal:  Nat Commun       Date:  2020-11-30       Impact factor: 14.919

8.  Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.

Authors:  Siqi Chen; Ping Xie; Matthew Cowan; Hao Huang; Horacio Cardenas; Russell Keathley; Edward J Tanner; Gini F Fleming; John W Moroney; Alok Pant; Azza M Akasha; Ramana V Davuluri; Masha Kocherginsky; Bin Zhang; Daniela Matei
Journal:  J Clin Invest       Date:  2022-07-15       Impact factor: 19.456

Review 9.  Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade.

Authors:  Elisa Peranzoni; Vincenzo Ingangi; Elena Masetto; Laura Pinton; Ilaria Marigo
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.